Proteomic analysis reveals sex-specific biomarker signature in postural orthostatic tachycardia syndrome, BMC Cardiovascular Disorders

Background Postural orthostatic tachycardia syndrome (POTS) is a variant of cardiovascular (CV) autonomic disorder of unknown etiology characterized by an excessive heart rate increase on standing and orthostatic intolerance. In this study we sought to identify novel CV biomarkers potentially implicated in POTS pathophysiology. Methods We conducted a nested case-control study within the Syncope Study of Unselected Population in Malmö (SYSTEMA) cohort including 396 patients (age range, 15–50 years) with either POTS (n = 113) or normal hemodynamic response during passive head-up-tilt test (n = 283). We used a targeted approach to explore changes in cardiovascular proteomics associated with POTS through a sequential two-stage process including supervised principal component analysis and univariate ANOVA with Bonferroni correction. Results POTS patients were younger (26 vs. 31 years; p < 0.001) and had lower BMI than controls. The discovery algorithm identified growth hormone (GH) and myoglobin (MB) as the most specific biomarker fingerprint for POTS. Plasma level of GH was higher (9.37 vs 8.37 of normalised protein expression units (NPX); p = 0.002), whereas MB was lower (4.86 vs 5.14 NPX; p = 0.002) in POTS compared with controls. In multivariate regression analysis, adjusted for age and BMI, and stratified by sex, lower MB level in men and higher GH level in women remained independently associated with POTS. Conclusions Cardiovascular proteomics analysis revealed sex-specific biomarker signature in POTS featured by higher plasma level of GH in women and lower plasma level of MB in men. These findings point to sex-specific immune-neuroendocrine dysregulation and deconditioning as potentially key pathophysiological traits underlying POTS.

Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus. - Abstract - Europe PMC

Postural orthostatic tachycardia syndrome: clinical presentation, aetiology and management - Fedorowski - 2019 - Journal of Internal Medicine - Wiley Online Library

1-L Transcription in Parkinson's Disease

Small molecule metabolites: discovery of biomarkers and therapeutic targets. - Abstract - Europe PMC

1-L Transcription in Parkinson's Disease

43rd International Symposium on Intensive Care & Emergency Medicine, Critical Care

iBright Imaging System Resources

Noninvasive Vagus Nerve Stimulation in Postural Tachycardia Syndrome: A Randomized Clinical Trial - ScienceDirect

Apparent risks of postural orthostatic tachycardia syndrome diagnoses after COVID-19 vaccination and SARS-Cov-2 Infection

Circulating levels of growth hormone in postural orthostatic tachycardia syndrome

Postural orthostatic tachycardia syndrome - MEpedia

Postural orthostatic tachycardia syndrome Warrior: Postural orthostatic tachycardia syndrome awareness journal Book, A Daily Mood, Pain, Symptoms

Postural Orthostatic Tachycardia Syndrome – Overview and Focus on Non-Pharmacological Approaches (Q&A Report) - InsideScientific

Dysautonomia: What Is It, Causes, Signs, Symptoms, Diagnosis, and

Postural orthostatic Tachycardia Syndrome Awareness